gms | German Medical Science

24. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie (GAA)

Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie

30.11. - 01.12.2017, Erfurt

General Practitioners' Perception of Interprofessional Collaboration with Pharmacists

Meeting Abstract

Suche in Medline nach

  • corresponding author presenting/speaker Olaf Rose - College of Pharmacy, Department of Pharmacotherapy & Translational Research, College of Pharmacy, University of Florida, Gainesville, United States
  • author Katharina Richling - College of Pharmacy, Department of Pharmacotherapy & Translational Research, College of Pharmacy, University of Florida, Gainesville, United States
  • author Juliane Köberlein-Neu - Center for Health Economics and Health Services Research, Schumpeter School of Business and Economics, University of Wuppertal, Wuppertal, Germany

Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie e.V. (GAA). 24. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie. Erfurt, 30.11.-01.12.2017. Düsseldorf: German Medical Science GMS Publishing House; 2017. Doc17gaa93

doi: 10.3205/17gaa93, urn:nbn:de:0183-17gaa932

Veröffentlicht: 5. Dezember 2017

© 2017 Rose et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe



Background: Despite provided national data on outcomes [1], [2], [3], implementation of Medication Review and Medication Management into routine care of pharmacists shows little progress in Germany in 2017. Although it has been voted as the future core activity of pharmacists [4], education remains unchanged and pharmacists’ organizations did not reach any contract with healthcare stakeholders so far. Besides missing clinical education, further barriers for pharmaceutical care services are expected to appear in interprofessional collaboration with general practitioners (GPs) [5], [6], [7], [8], [9]. Better understanding of the GP`s perception of collaboration with pharmacists is expected to facilitate future implementation of Medication Review and was the aim of this study.

Materials and Methods: All GPs, who participated in the WestGem study on collaborative Medication Management were approached for follow-up interviews in 2016, one year after the study was concluded. The WestGem study analyzed changes in the Medication Appropriateness Index as a measure of quality of therapy and was conducted as a cluster randomized trial. The investigator appeared as a University affiliated researcher. Interviews were recorded and written down. Results of this qualitative approach are presented descriptively.

Results: The study covered 6 GPs who were responsible for 78 former study patients, representing 55% of the study population. Physicians were 58 years old on average, mostly male (66.6%) and personally responsible for their clinic. They mentioned better insight into the patient’s drug regimen and an improvement in patient safety as achievements of collaboration with pharmacists. Limited time in daily practice was found to be a major cause to prevent translation of results of the Medication Review to the patients’ drug regimen.

Conclusion: Most GPs of the study appreciated collaboration with pharmacists on drug therapy. A future collaboration should be tailored to the tight working schedule of a GP in daily practice. Medication Reviews need to be concise and prioritized. As implementing potential suggestions to the patient`s drug regimen is time consuming, GPs efforts need to be acknowledged and reimbursed.


Wolf C, Pauly A, Mayr A, et al. Pharmacist-Led Medication Reviews to Identify and Collaboratively Resolve Drug-Related Problems in Psychiatry - A Controlled, Clinical Trial. PLoS One. 2015;10(11):e0142011. doi:10.1371/journal.pone.0142011 Externer Link
Pauly A, Wolf C, Mayr A, Lenz B, Kornhuber J, Friedland K. Effect of a Multi-Dimensional and Inter-Sectoral Intervention on the Adherence of Psychiatric Patients. PLoS One. 2015;10(10):e0139302. doi:10.1371/journal.pone.0139302 Externer Link
Koberlein-Neu J, Mennemann H, Hamacher S, et al. Interprofessional Medication Management in Patients With Multiple Morbidities. Dtsch Arztebl Int. 2016;113(44):741-748. doi:10.3238/arztebl.2016.0741 Externer Link
Bryant LJM, Coster G, Gamble GD, McCormick RN. General practitioners' and pharmacists' perceptions of the role of community pharmacists in delivering clinical services. Res Social Adm Pharm. 2009;5(4):347-362. doi:10.1016/j.sapharm.2009.01.002 Externer Link
Bundesvereinigung Deutscher Apothekerverbände. Apotheke 2030, Perspektiven zur pharmazeutischen Versorgung in Deutschland. Accessed August 15, 2017. Externer Link
Dobson RT, Taylor JG, Henry CJ, et al. Taking the lead: Community pharmacists' perception of their role potential within the primary care team. Res Social Adm Pharm. 2009;5(4):327-336. doi:10.1016/j.sapharm.2008.11.002 Externer Link
Hughes CM, McCann S. Perceived interprofessional barriers between community pharmacists and general practitioners: A qualitative assessment. Br J Gen Pract. 2003;53(493):600-606.
Kelly DV, Bishop L, Young S, Hawboldt J, Phillips L, Keough TM. Pharmacist and physician views on collaborative practice: Findings from the community pharmaceutical care project. Can Pharm J (Ott). 2013;146(4):218-226. doi:10.1177/1715163513492642 Externer Link
Chen TF. Pharmacist-Led Home Medicines Review and Residential Medication Management Review: The Australian Model. Drugs Aging. 2016;33(3):199-204. doi:10.1007/s40266-016-0357-2 Externer Link